newsfilter
← Latest News
Business Wire·

Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025

Conference Call to be Held at 8:30 a.m. ET Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative